SCHEMBL1010957

SCHEMBL1010957

COOC(=O)c1ccc2c(c1)C(C)(C)c1c3c(c4ccccc4c1-2)OC(c1ccc(OC)cc1)(c1ccc(OC)cc1)C=C3

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A1 P60842 1/20 0.32
VDR P11473 1/20 0.32
ELANE P08246 1/20 0.31
CTSG P08311 1/20 0.31
PRTN3 P24158 1/20 0.31
HTT P42858 2/20 0.31
GPR84 Q9NQS5 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
ALDH1A1 P00352 3/20 0.30
KDM4E B2RXH2 2/20 0.30
HPGD P15428 2/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MAPT P10636 1/20 0.30
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3136357 0.88 VDR (0.37) EIF4A1VDRELANECTSGPRTN3
SCHEMBL26640830 0.88 HTT (0.36) EIF4A1HTTGPR84ALDH1A1KDM4E
SCHEMBL25844158 0.87 TP53 (0.35) EIF4A1VDRHTTGPR84ALDH1A1
SCHEMBL25604638 0.86 CA1 (0.38) EIF4A1ELANECTSGPRTN3HTT
SCHEMBL25601770 0.85 RXFP1 (0.36) EIF4A1KDM4ELMNACYP2C19MAPT
SCHEMBL25844011 0.85 TP53 (0.32) HTTGPR84ALDH1A1KDM4EHPGD
SCHEMBL25602568 0.85 EIF4A1 (0.36) EIF4A1GPR84
SCHEMBL1010912 0.84 KMT2A (0.39) EIF4A1VDRELANECTSGPRTN3
SCHEMBL720553 0.84 KDM4E (0.31) HTTALDH1A1KDM4EHPGDMEN1
SCHEMBL9898796 0.84 KDM4E (0.31) HTTALDH1A1KDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1872173-B9 PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME TRANSITIONS OPTICAL INC (US) 2011-01-05 EP claimed
EP-1872173-B1 PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME TRANSITIONS OPTICAL INC (US) 2010-04-14 EP claimed
US-20060226402-A1 Ophthalmic devices comprising photochromic materials having extended PI-conjugated systems KIM BEON-KYU 2006-10-12 US claimed
US-20060228557-A1 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same TRANSITIONS OPTICAL, INC. 2006-10-12 US claimed
EP-1872173-B9 PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME TRANSITIONS OPTICAL INC (US) 2011-01-05 EP disclosed
EP-1872173-B1 PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME TRANSITIONS OPTICAL INC (US) 2010-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060228557-A1 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same INCENP, PCNA, INTS6 EIF4A1 1326/4885VDR 1578/4885ELANE 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.